Why Is Capricor Therapeutics ( $CAPR) Stock Up +14.12% Today? (Find out why any stock moved today on Tickeron.) CAPR shares climbed 14.12% to $9.78 in intraday trading, up from a prior close of $8.57. The primary catalyst was new 24-month HOPE-3 extension data for Deramiocel in Duchenne muscular dystrophy (DMD), presented at the World Muscle Society congress. Patients switching from placebo to Deramiocel showed a 76% slower upper-limb decline and a 66% slower decline in elbow-related function. $ENLV $PHVS $VRAX $WVE